Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Papulopustular Rosacea”

8 trials

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT03276936
What this trial is testing

Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea

Who this might be right for
Papulopustular Rosacea
Vyne Therapeutics Inc. 504
Testing effectiveness (Phase 2)Study completedNCT03079531
What this trial is testing

Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea

Who this might be right for
Papulopustular Rosacea
Anne Chang 24
Testing effectiveness (Phase 2)WithdrawnNCT06532136
What this trial is testing

Deucravacitinib Rosacea

Who this might be right for
Papulopustular Rosacea
Icahn School of Medicine at Mount Sinai
Testing effectiveness (Phase 2)Study completedNCT03050086
What this trial is testing

Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea

Who this might be right for
Moderate to Severe Papulopustular Rosacea
BioPharmX, Inc. 30
Large-scale testing (Phase 3)Study completedNCT02840461
What this trial is testing

Clinical Endpoint Study of Ivermectin 1% Cream

Who this might be right for
Moderate to Severe Papulopustular Rosacea
Actavis Inc. 630
Testing effectiveness (Phase 2)Study completedNCT01045551
What this trial is testing

Open Label Pilot Study of Apremilast in Treatment of Rosacea

Who this might be right for
Erythematotelangiectatic RosaceaPapulopustular Rosacea
Julian M. Mackay-Wiggan 10
Testing effectiveness (Phase 2)UnknownNCT03864978
What this trial is testing

Safety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test

Who this might be right for
Papulopustular Rosacea
Alfasigma S.p.A. 236
Testing effectiveness (Phase 2)Study completedNCT05150587
What this trial is testing

Safety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea

Who this might be right for
Papulopustular Rosacea
Alfasigma S.p.A. 216

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation